Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 4:06 PM View:  | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 01-Oct-24 | Option Exercise | 2,491 | -- | -- | 21% 11.72K to 14.21K | |
| 04-Oct-24 4:06 PM View: | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 01-Oct-24 | Payment of Exercise | 732 | $24.27 | $17,765.60 | (5%) 14.21K to 13.48K | |
| 11-Jul-24 4:32 PM View: | Fishetti Gary P Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 27% 21.68K to 27.45K | |
| 11-Jul-24 4:32 PM View: | Conley Sheryl L Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 25% 22.63K to 28.4K | |
| 11-Jul-24 4:33 PM View: | Jellison William R Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 182% 3.17K to 8.94K | |
| 11-Jul-24 4:34 PM View: | Richard Stephen Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 21% 27.94K to 33.71K | |
| 11-Jul-24 4:31 PM View: | Capper Joseph H Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 1233% 0.47K to 6.24K | |
| 11-Jul-24 4:33 PM View: | Henneman John B III Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 19% 29.94K to 35.71K | |
| 11-Jul-24 4:34 PM View: | Larsen Glenn R. Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 19% 30.32K to 36.09K | |
| 11-Jul-24 4:35 PM View: | Vogt Susan L N Director | Anika Therapeutics Inc. (ANIK) | 09-Jul-24 | Grant | 5,771 | -- | -- | 19% 30.28K to 36.05K | |
| 05-Jun-24 4:11 PM View: | Jellison William R Director | Anika Therapeutics Inc. (ANIK) | 03-Jun-24 | Grant | 468 | -- | -- | 17% 2.7K to 3.17K | |
| 05-Jun-24 4:10 PM View: | Capper Joseph H Director | Anika Therapeutics Inc. (ANIK) | 03-Jun-24 | Grant | 468 | -- | -- | 100% 0 to 0.47K | |
| 12-Mar-24 8:02 PM View: | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Payment of Exercise | 1,720 | $25.58 | $44,000.60 | (13%) 12.81K to 11.09K | |
| 12-Mar-24 8:01 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Payment of Exercise | 5,638 | $25.59 | $144,284.00 | (11%) 52.59K to 46.95K | |
| 12-Mar-24 8:03 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Payment of Exercise | 4,936 | $25.59 | $126,306.00 | (13%) 37.93K to 32.99K | |
| 12-Mar-24 8:02 PM View: | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Option Exercise | 5,856 | -- | -- | 84% 6.95K to 12.81K | |
| 12-Mar-24 8:04 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Payment of Exercise | 27,980 | $25.61 | $716,629.00 | (15%) 191.42K to 163.44K | |
| 12-Mar-24 8:01 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Option Exercise | 19,201 | -- | -- | 58% 33.39K to 52.59K | |
| 12-Mar-24 8:03 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Option Exercise | 16,809 | -- | -- | 80% 21.12K to 37.93K | |
| 12-Mar-24 8:04 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 11-Mar-24 | Option Exercise | 64,480 | -- | -- | 51% 126.94K to 191.42K | |
| 03-Oct-23 4:31 PM View: | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 01-Oct-23 | Payment of Exercise | 732 | $18.63 | $13,637.20 | (13%) 5.78K to 5.05K | |
| 03-Oct-23 4:31 PM View: | Nunes Anne SVP, Chief Operations Officer | Anika Therapeutics Inc. (ANIK) | 01-Oct-23 | Option Exercise | 2,491 | -- | -- | 76% 3.29K to 5.78K | |
| 11-Aug-23 4:30 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 10-Aug-23 | Payment of Exercise | 1,133 | $18.58 | $21,051.10 | (3%) 34.37K to 33.23K | |
| 11-Aug-23 4:30 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 10-Aug-23 | Option Exercise | 3,859 | -- | -- | 13% 30.51K to 34.37K | |
| 16-Jun-23 4:16 PM View: | Richard Stephen Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 30% 21.44K to 27.94K | |
| 16-Jun-23 4:16 PM View: | Henneman John B III Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 28% 23.44K to 29.94K | |
| 16-Jun-23 4:16 PM View: | Larsen Glenn R. Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 27% 23.82K to 30.32K | |
| 16-Jun-23 4:17 PM View: | Vogt Susan L N Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 27% 23.78K to 30.28K | |
| 16-Jun-23 4:16 PM View: | Fishetti Gary P Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 43% 15.18K to 21.68K | |
| 16-Jun-23 4:17 PM View: | Thompson Jeffery S Director | Anika Therapeutics Inc. (ANIK) | 14-Jun-23 | Grant | 6,500 | -- | -- | 26% 25.07K to 31.57K | |
| 28-Apr-23 4:30 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 26-Apr-23 | Payment of Exercise | 10,900 | $26.34 | $287,106.00 | (8%) 136.9K to 126.0K | |
| 28-Apr-23 4:30 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 26-Apr-23 | Option Exercise | 24,575 | -- | -- | 22% 112.32K to 136.9K | |
| 17-Apr-23 4:32 PM View: | Fishetti Gary P Director | Anika Therapeutics Inc. (ANIK) | 13-Apr-23 | Grant | 12,858 | -- | -- | 554% 2.32K to 15.18K | |
| 14-Mar-23 4:46 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Payment of Exercise | 2,250 | $26.10 | $58,725.00 | (10%) 22.54K to 20.29K | |
| 14-Mar-23 4:46 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Option Exercise | 7,663 | -- | -- | 52% 14.88K to 22.54K | |
| 14-Mar-23 4:47 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Payment of Exercise | 2,609 | $26.10 | $68,094.90 | (8%) 32.45K to 29.84K | |
| 14-Mar-23 4:47 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Option Exercise | 8,888 | -- | -- | 38% 23.56K to 32.45K | |
| 14-Mar-23 4:46 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Payment of Exercise | 13,211 | $26.10 | $344,807.00 | (11%) 125.53K to 112.32K | |
| 14-Mar-23 4:46 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 10-Mar-23 | Option Exercise | 30,060 | -- | -- | 31% 95.47K to 125.53K | |
| 10-Mar-23 4:52 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Payment of Exercise | 1,303 | $26.91 | $35,063.70 | (5%) 24.86K to 23.56K | |
| 10-Mar-23 4:52 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Option Exercise | 4,439 | -- | -- | 22% 20.42K to 24.86K | |
| 10-Mar-23 4:51 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Payment of Exercise | 4,232 | $26.91 | $113,883.00 | (4%) 99.7K to 95.47K | |
| 10-Mar-23 4:51 PM View: | Blanchard Cheryl R President, CEO, Director Director | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Option Exercise | 14,419 | -- | -- | 17% 85.29K to 99.7K | |
| 10-Mar-23 4:51 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Payment of Exercise | 1,081 | $26.91 | $29,089.70 | (7%) 15.96K to 14.88K | |
| 10-Mar-23 4:51 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 09-Mar-23 | Option Exercise | 3,683 | -- | -- | 30% 12.27K to 15.96K | |
| 07-Mar-23 4:34 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 04-Mar-23 | Payment of Exercise | 734 | $31.59 | $23,187.10 | (6%) 13.01K to 12.27K | |
| 07-Mar-23 4:34 PM View: | Colleran David EVP, General Counsel, Corp Sec | Anika Therapeutics Inc. (ANIK) | 04-Mar-23 | Option Exercise | 2,500 | -- | -- | 24% 10.51K to 13.01K | |
| 11-Aug-22 4:11 PM View: | Levitz Michael L EVP, CFO, Treasurer | Anika Therapeutics Inc. (ANIK) | 10-Aug-22 | Option Exercise | 3,859 | -- | -- | 23% 16.56K to 20.42K | |
| 10-Jun-22 4:17 PM View: | Vogt Susan L N Director | Anika Therapeutics Inc. (ANIK) | 08-Jun-22 | Grant | 7,954 | -- | -- | 50% 15.82K to 23.78K | |
| 10-Jun-22 4:16 PM View: | Henneman John B III Director | Anika Therapeutics Inc. (ANIK) | 08-Jun-22 | Grant | 7,954 | -- | -- | 51% 15.48K to 23.44K |
